A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

Clinical trial NCT05698524 · RECRUITING

Trial details

NCT number: NCT05698524
Sponsor: University of Nebraska
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent High Grade Glioma Anaplastic Astrocytoma Anaplastic Oligodendroglioma Glioblastoma Gliosarcoma

Start date: 2023-06-26
Primary completion: 2027-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.